-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M6fozXwPrPXYRVjjUH7R8VThwrqMD3h6tmveW2wboCI2T/iHdvQbNH5/dgqwUOik QZBtLJT8Aan+7I8sdcgPUg== 0001140361-10-037697.txt : 20100917 0001140361-10-037697.hdr.sgml : 20100917 20100917141537 ACCESSION NUMBER: 0001140361-10-037697 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100915 FILED AS OF DATE: 20100917 DATE AS OF CHANGE: 20100917 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MAY RON CENTRAL INDEX KEY: 0001203416 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 101077915 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4 1 doc1.xml FORM 4 X0303 4 2010-09-15 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001203416 MAY RON SOUTHERN PROSTHETIC SUPPLY, INC. P.O. BOX 406 ALPHARETTA GA 30009 0 1 0 0 Pres./Southern Prosthetic Common Stock 2010-09-15 4 S 0 4914 15.00 D 24008 D Option to Buy 16.75 2003-09-17 2012-09-16 Common Stock 8000 8000 D Includes (i) unvested restricted shares which total 3,750 shares of stock from an initial grant of 3,750 shares of restricted stock made on March 30, 2010; (ii) unvested restricted shares that total 12,758 shares of stock from an initial grant of 17,010 shares of restricted stock and performance shares made on November 13, 2008; and (iii) unvested restricted shares that total 7,500 shares of stock from an initial grant of 30,000 shares of restricted stock and performance shares made on August 9, 2007. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. This option vested over a four-year period from the date of grant and is now fully vested. /s/ Teri L. Champ, Attorney-in-Fact for Ron May 2010-09-17 -----END PRIVACY-ENHANCED MESSAGE-----